<span item_type="fundamental" item_id="37a4b82ca2f44ffa59e024023ef62637" counter_id="ST/US/EDBLW" env="prod"></span><span item_type="announcement" item_id="648609176610078849" env="prod"></span><p>Revenue: As of FY2026 Q1, the actual value is USD 3.341 M.</p><p>EPS: As of FY2026 Q1, the actual value is USD -5.25.</p><p>EBIT: As of FY2026 Q1, the actual value is USD -6.528 M.</p><p></p><h3>Financial &amp; Operating Highlights (Three Months Ended March 31, 2026 vs. 2025)</h3><h4>Revenue</h4><p>Revenue increased approximately 22.9% to $3.3 million for the three months ended March 31, 2026, compared to $2.7 million for the same period in 2025, an increase of approximately $0.6 million <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. The increase was primarily driven by continued growth in the Company’s cut herb portfolio <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p><h4>Segment Revenue Growth (Year-over-Year)</h4><p>Cut Herb Sales increased approximately 46% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Vitamin and Supplements Sales increased approximately 27% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. International Sales increased approximately 50% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Condiment Sales increased approximately 51% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p><h4>Operating Expenses</h4><p>Total operating expenses were $10.0 million for the three months ended March 31, 2026, up from $5.6 million for the same period in 2025, representing a $4.4 million or 77.5% increase <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. This increase was primarily due to higher cost of goods sold and increased depreciation and amortization <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Cost of goods sold was $4.39 million in Q1 2026, compared to $2.79 million in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Selling, general and administrative expenses were $2.91 million in Q1 2026, compared to $2.61 million in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Depreciation and amortization expenses were $2.72 million in Q1 2026, significantly up from $0.25 million in Q1 2025, primarily due to accelerated depreciation of certain fixed assets related to the pivot to RTD clean nutrition manufacturing <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p><h4>Loss from Operations</h4><p>Loss from operations was - $6.68 million for the three months ended March 31, 2026, compared to - $2.93 million for the same period in 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p><h4>Income Tax Benefit</h4><p>The Company recorded an income tax benefit of approximately $3.4 million for the three months ended March 31, 2026, mainly from a valuation allowance release connected to the sale of certain state tax benefits <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p><h4>Other Income (Expenses)</h4><p>Interest expense, net was - $0.15 million in Q1 2026, compared to - $0.44 million in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Loss on sale of tax benefit was - $0.24 million in Q1 2026 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Other income was $0.04 million in Q1 2026, compared to $0.04 million in Q1 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p><h4>Net Loss</h4><p>Net loss was - $3.67 million for the three months ended March 31, 2026, compared to - $3.32 million for the same period in 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p><h3>Outlook / Guidance</h3><p>Edible Garden believes the ready-to-drink (RTD) category presents a significant long-term opportunity, with the global RTD market projected to grow from approximately $842.5 billion in 2025 to roughly $1.26 trillion by 2033 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. The Company anticipates growing demand for scalable domestic production of clean-label, shelf-stable functional nutrition products <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>. Edible Garden is focused on executing these opportunities to potentially achieve improved margins, greater scalability, and long-term value creation <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1809750/000147793226003155/edbl_ex991.htm"></span>.</p>

EDIBLE GARDEN AG INC C/WTS (TO PUR COM) | 8-K: FY2026 Q1 Revenue: USD 3.341 M